WORK Medical: 325,000 shares reported (18.9%)

WORK Medical Technology Group LTD reported a Schedule 13G filing showing Kelly Habbas beneficially owns 325,000 Class A Ordinary Shares.

Rhea-AI Filing Summary

WORK Medical Technology Group LTD reported a Schedule 13G filing showing Kelly Habbas beneficially owns 325,000 Class A Ordinary Shares. The filing states Habbas has sole voting and dispositive power over 325,000 shares, representing 18.9% of the class. The filing was signed on 06/04/2026 and includes a commentary that the filing was late due to lack of EDGAR credentials; the filer applied for access and filed promptly upon receiving credentials.

Insights

Equity Ownership Analyst

Large passive stake reported—beneficial ownership and sole control documented.

The filing documents a 325,000-share beneficial position with sole voting and dispositive power, equal to 18.9% of the Class A ordinary shares. This establishes a material ownership stake that must be tracked for future disclosures.

Timing of any future changes in holdings will depend on additional filings; subsequent filings may show increases, decreases, or transfers.

Compliance & SEC Filings Specialist

Late Schedule 13G corrected with explanatory footnote about EDGAR access.

The statement explains the late filing resulted from lack of EDGAR credentials and that the filer applied for access and filed promptly after receiving credentials. This provides a procedural explanation rather than an ownership change.

Watch for any amendments or Form 3/4 filings if the ownership becomes active or voting arrangements change.

Key Figures

Beneficial ownership: 325,000 shares Percent of class: 18.9% Sole voting power: 325,000 shares +2 more

5 metrics

Beneficial ownership 325,000 shares Class A Ordinary Shares

Percent of class 18.9% Percent of Class A Ordinary Shares

Sole voting power 325,000 shares Sole power to vote as disclosed in filing

Sole dispositive power 325,000 shares Sole power to dispose as disclosed in filing

Filing signature date 06/04/2026 Date the Schedule 13G was signed

Key Terms

Schedule 13G, Beneficially owned, Sole dispositive power

3 terms

Schedule 13G regulatory

"Name of issuer: WORK Medical Technology Group LTD; filing is a Schedule 13G"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

Beneficially owned financial

"Amount beneficially owned: 325,000"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 325,000"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Kelly Habbas report in WORK Medical (WOK)?

Kelly Habbas reports beneficial ownership of 325,000 Class A Ordinary Shares. The filing states this equals 18.9% of the class and that Habbas holds sole voting and dispositive power over these shares.

What voting and disposition rights are disclosed in the Schedule 13G?

The Schedule 13G discloses that Kelly Habbas has sole power to vote and sole power to dispose of 325,000 shares. Shared voting and dispositive powers are reported as zero in the filing.

When was the Schedule 13G signed and why was it late?

The filing is signed on 06/04/2026. The report explains the late filing was due to the filer not having EDGAR credentials and states the filer applied for access and filed promptly after obtaining credentials.

Does the filing indicate active trading or changes to the position?

The Schedule 13G shows current beneficial ownership and control but does not state any purchase or sale transaction in this excerpt. Future transaction details would appear in additional filings if they occur.

How should investors interpret a Schedule 13G showing an 18.9% stake?

A Schedule 13G reflects beneficial ownership at a reported level; here it documents 18.9% ownership and sole control over those shares. Any change in the holder's intentions or transactions would be disclosed in later filings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/04/2026 - 02:48 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

WORK Medical Technology Group LTD

(Name of Issuer)

Class A Ordinary Shares

(Title of Class of Securities)

G9767H125

(CUSIP Number)

05/26/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): G9767H125

1

Names of Reporting Persons

Habbas Kelly Khalid

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 325,000.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 325,000.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

325,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

18.9 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: Late filing was due to filer not having EDGAR credentials. Filer applied for EDGAR access immediately upon identifying the filing obligation and filed promptly upon receiving credentials.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: WORK Medical Technology Group LTD
(b)	Address of issuer's principal executive offices: 1/88 COOK ST, AUCKLAND CITY, NEW ZEALAND, 1001
Item 2.
(a)	Name of person filing: Kelly Habbas
(b)	Address or principal business office or, if none, residence: 15068 Mountain View Lane Frisco, TX 75035
(c)	Citizenship: United States
(d)	Title of class of securities: Class A Ordinary Shares
(e)	CUSIP Number(s): G9767H125
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 325,000
(b)	Percent of class: 18.9 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 325,000
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 325,000
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Habbas Kelly Khalid

Signature:	Kelly Habbas
Name/Title:	Individual Investor
Date:	06/04/2026